Rupp M T
Department of Pharmacy Practice, Purdue University, West Lafayette, IN 47907.
Ann Pharmacother. 1992 Dec;26(12):1580-4. doi: 10.1177/106002809202601218.
The purpose of this analysis was to estimate the economic value created by community pharmacists who routinely screen for and correct prescribing-related problems during the course of their dispensing activities.
Three expert judges evaluated the documented interventions of community pharmacists practicing in five states.
The judges agreed that 28.3 percent of the identified problems could have resulted in patient harm had the pharmacist not intervened to correct the problem. The direct cost of medical care that was avoided as a result of pharmacists' intervention activities was estimated to be $122.98 per problematic prescription, or +f42.32 per each new prescription order that was screened during the study.
Clinical pharmacy services can and do create significant value by enhancing the achievement of positive patient outcomes and by avoiding negative outcomes. Research to develop reliable methods for measuring and monitoring the value of clinical pharmacy services must continue. Mechanisms must be created to encourage and reward pharmacists who consistently provide services that add measurable value to patient care.
本分析旨在评估社区药剂师在配药过程中常规筛查并纠正处方相关问题所创造的经济价值。
三位专家评委对在五个州执业的社区药剂师的记录干预措施进行了评估。
评委们一致认为，在已识别出的问题中，若药剂师未进行干预纠正，28.3% 的问题可能会对患者造成伤害。因药剂师的干预活动而避免的医疗直接成本估计为每份有问题处方122.98美元，或在研究期间筛查的每份新处方订单42.32英镑。
临床药学服务能够且确实通过促进积极的患者治疗结果的实现以及避免负面结果创造显著价值。必须继续开展研究以开发可靠的方法来衡量和监测临床药学服务的价值。必须建立机制来鼓励和奖励那些持续提供能为患者护理增添可衡量价值的服务的药剂师。
